# A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension

> **NCT00348062** · PHASE4 · COMPLETED · sponsor: **Innovative Medical**

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Bimatoprost

## Key facts

- **NCT ID:** NCT00348062
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348062, "A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00348062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*